Metropolitan Life Insurance Company (MetLife)’s Lexeo Therapeutics LXEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-599
Closed -$9.39K 1213
2024
Q1
$9.39K Buy
+599
New +$9.39K ﹤0.01% 2152